Cross-talk between skeleton and pancreas morphogeneses during development

发育过程中骨骼和胰腺形态发生之间的串扰

• 批准号: 8806907
• 负责人: Patricia Florence Ducy
• 金额: $ 21.12万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-01 至 2017-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8806907
• 关键词: Address; Adult; Affect; Agreement; Biological Markers; Biology; Bone Development; Bone Resorption; Cell Proliferation; Cell Proliferation Regulation; Cell physiology; Cells; Data; Defect; Development; Diet; Embryo; Embryonic Development; Fatty acid glycerol esters; G-Protein-Coupled Receptors; Gene Expression; Genotype; Glucose; Goals; Hormones; Human; Insulin; Islets of Langerhans; Link; Mediating; Methods; Molecular; Morphogenesis; Mothers; Mouse Strains; Mus; Organ; Osteoblasts; Osteocalcin; Osteoclasts; Pancreas; Phenotype; Placenta; Play; Pregnancy; Process; Production; Receptor Signaling; Regulation; Role; Serum; Severities; Signal Transduction; Skeleton; Testing; TimeLine; base; bone; bone cell; bone metabolism; feeding; glucose metabolism; in vivo; insulin secretion; insulin signaling; meetings; mouse model; novel; offspring; osteoblast differentiation; pancreas development; progenitor; public health relevance; pup; skeletogenesis; transcription factor

DESCRIPTION (provided by applicant): This project has two, intrinsically linked, goals. The first one is to identify cross-regulatory mechanisms between bone and pancreas morphogenesis during development. The second one is to assess whether this cross-regulation involves a maternal component. A growing body of studies has established the existence of a cross-talk of glucose and bone metabolisms during adulthood. On the one hand osteoblasts, the bone-forming cells, secrete a hormone, osteocalcin, regulating insulin synthesis and secretion among other processes. On the other hand, insulin signaling in osteoblasts regulates osteocalcin production and its resorption-mediated activation. Hence, during adulthood there is a feed-forward regulatory loop whereby insulin secretion by b-cells enhances the production and activity of osteocalcin, which in turns promotes insulin synthesis. More recently, we have shown that osteocalcin also controls b-cell proliferation in the developing embryo. Drawing a parallel with the functional crosstalk between bone cells and b-cells existing in adults, we hypothesize that a regulatory loop between osteocalcin and insulin could exist during development and could contribute to the formation of the skeleton and endocrine pancreas in the embryo. Accordingly, pups lacking insulin signaling in osteoblasts have a decrease in b-cell proliferation and lower serum levels of a biomarker of bone resorption compared to control littermates. Another recently identified feature of osteocalcin is its ability to cross the placenta during pregnancy and reach the embryo before it can produce its own. Hence, maternal osteocalcin could play a role in regulating insulin production and b- cell proliferation during pancreas development. In agreement with this hypothesis we have observed that adult Ocn+/- mice fed a high fat diet become more glucose intolerant when they are born from an Ocn-/- mother than from an Ocn+/- mother. Taken together, these novel findings and our preliminary data raise the prospect that maternal osteocalcin could initiate, or contribute to, a cross-regulation between osteocalcin and insulin that influences bone and pancreas development. To demonstrate this hypothesis we propose the following Specific Aims: 1. To determine whether maternal osteocalcin influences insulin production and b-cell proliferation in the embryo 2. To test whether insulin signaling in osteoblasts contributes to the regulation of b-cell proliferation by osteocalcin during development 3. To assess whether skeletogenesis is dependent of the embryonic production of insulin during development We would like to emphasize here that the genetically modified mouse models required to perform these studies have already been generated and therefore that achieving these aims can meet the timeline of a R21 project.

描述（由申请人提供）：该项目具有两个本质上链接的目标。第一个是确定发育过程中骨骼和胰腺形态发生之间的交叉调节机制。第二个是评估这种交叉调节是否涉及母体成分。越来越多的研究已经建立了成年期间葡萄糖和骨代谢的串扰。一方面，成骨细胞，骨形成细胞，分泌一种激素，骨钙素，调节胰岛素合成和分泌以及其他过程。另一方面，成骨细胞中的胰岛素信号传导调节骨钙素的产生及其吸收介导的激活。因此，在成年期间，有一个喂养前向调节环，B细胞的胰岛素分泌增强了骨钙素的产生和活性，又促进了胰岛素合成。最近，我们表明骨钙素还控制发育中的胚胎中的B细胞增殖。与成人存在的骨细胞和B细胞之间的功能性串扰相似，我们假设在发育过程中可能存在骨钙素和胰岛素之间的调节环，并可能有助于胚胎中骨架和内分泌胰腺的形成。因此，与对照同窝仔相比，在成骨细胞中缺乏胰岛素信号传导的幼崽的B细胞增殖和较低的血清血清水平降低。骨钙素的另一个最近确定的特征是它在怀孕期间越过胎盘并在产生自己的胚胎之前到达胎盘的能力。因此，孕产妇的骨钙素可以在调节胰腺发育过程中调节胰岛素产生和B细胞增殖方面发挥作用。与这一假设一致，我们已经观察到，喂养高脂饮食的成年OCN +/-小鼠在OCN - / - 母亲出生时，与OCN +/-母亲相比，它们的葡萄糖不耐受。综上所述，这些新颖的发现和我们的初步数据增加了孕产妇骨钙素可以引发或促进骨钙素和胰岛素之间影响骨骼和胰腺发育的前景。为了证明这一假设，我们提出了以下特定目的：1。确定胚胎2中母体骨钙素影响胰岛素的产生和B细胞增殖是否是否影响成骨细胞中的胰岛素信号传导是否有助于在Ostecalcals ostecallasts中受Osteocalcin在OSTEOLCALCALID中的调节。开发3。为了评估骨骼生成是否取决于发育过程中胰岛素的胚胎产生，我们想在这里强调，进行这些研究所需的转基因小鼠模型已经产生，因此实现这些目标可以满足这些目标的时间表R21项目。